Hitachi Ventures and Optum Ventures contributed to a $110m round for precision immunology technology developer Scipher, already backed by Echo Health Ventures.
US-based precision immunology therapy developer Scipher Medicine closed a $110m funding round today featuring Hitachi Ventures and Optum Ventures, on behalf of electronics conglomerate Hitachi and healthcare services provider Optum respectively. Cowen Healthcare Investments led the round, which was filled out by Neuberger Berman, Laurion Capital, Monashee Investment Management, Northpond Ventures, aMoon, Khosla Ventures, Echo…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
